Bangkok Dusit Medical Stock Beta
| BDULFDelisted Stock | USD 0.73 0.00 0.00% |
Bangkok Dusit Medical fundamentals help investors to digest information that contributes to Bangkok Dusit's financial success or failures. It also enables traders to predict the movement of Bangkok Pink Sheet. The fundamental analysis module provides a way to measure Bangkok Dusit's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bangkok Dusit pink sheet.
Bangkok |
Bangkok Dusit Medical Company Beta Analysis
Bangkok Dusit's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Bangkok Dusit Beta | 0.43 |
Most of Bangkok Dusit's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bangkok Dusit Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, Bangkok Dusit Medical has a Beta of 0.4252. This is 50.56% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The beta for all United States stocks is notably lower than that of the firm.
Bangkok Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bangkok Dusit's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Bangkok Dusit could also be used in its relative valuation, which is a method of valuing Bangkok Dusit by comparing valuation metrics of similar companies.Bangkok Dusit is currently under evaluation in beta category among its peers.
As returns on the market increase, Bangkok Dusit's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bangkok Dusit is expected to be smaller as well.
Bangkok Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0739 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 13.03 B | |||
| Shares Owned By Institutions | 8.46 % | |||
| Price To Earning | 50.79 X | |||
| Price To Book | 4.91 X | |||
| Price To Sales | 0.14 X | |||
| Revenue | 74.45 B | |||
| Gross Profit | 24.99 B | |||
| EBITDA | 17.64 B | |||
| Net Income | 7.94 B | |||
| Cash And Equivalents | 16.66 B | |||
| Cash Per Share | 1.05 X | |||
| Total Debt | 12.5 B | |||
| Debt To Equity | 0.21 % | |||
| Current Ratio | 1.33 X | |||
| Book Value Per Share | 5.41 X | |||
| Cash Flow From Operations | 14.56 B | |||
| Earnings Per Share | 0.02 X | |||
| Number Of Employees | 45 | |||
| Beta | 0.43 | |||
| Market Capitalization | 13.53 B | |||
| Total Asset | 128.45 B | |||
| Retained Earnings | 28.38 B | |||
| Working Capital | (3.49 B) | |||
| Current Asset | 12.76 B | |||
| Current Liabilities | 16.25 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 128.45 B | |||
| Last Dividend Paid | 0.5 |
About Bangkok Dusit Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bangkok Dusit Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bangkok Dusit using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bangkok Dusit Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Bangkok Pink Sheet
If you are still planning to invest in Bangkok Dusit Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bangkok Dusit's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |